Thought Leadership
Blog

5 Key Considerations for Implementing Digital Technologies to Support Patients in China

Patient support is a hot topic in the life sciences space. Healthcare providers are consistently looking for ways to improve patient care and better support patients’ needs. In our previous post, we discussed how China was paving the way in leveraging digital health technologies...
Blog

C3 Summit Recap: Shaping the Future of eCOA/ePRO Highlights

The paper to digital migration of eCOAs/ePROs has been quite the journey, particularly in light of COVID-19. The rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local...
Blog

How Translation Can Increase Patient Engagement

As clinical research continues to expand across diverse markets and regions, it is imperative for data to reflect the global population. Data that is representative of all patients, including those of diverse backgrounds, ensures that the medical product in development serves and...
Blog

How CCMS Helps Healthcare Companies Prepare and Translate Medicare Compliance Content

In the United States, the Centers for Medicare & Medicaid Services (abbreviated "CMS" and found online at https://www.cms.gov/) aspires to the following credo:“We pledge to put patients first in all of our programs – Medicaid, Medicare, and the Health Insurance Exchanges. To do...
Blog

TransPerfect MT Earns Top Marks at International Machine Translation Competition

As machine translation (MT) technology continues to evolve, it’s increasingly important to look beyond the commercial sphere for the latest in innovation. At TransPerfect, we place special emphasis on the importance of engaging with the research communities specializing in MT...
Blog

The Benefits of Translation Memory for Low-Cost Markets and Life Sciences Companies

For life sciences companies expanding into new markets and conducting global clinical trials, accurate translation is critical for effectively communicating with patients. Companies are continually looking for ways to reduce costs and turnaround times of translating extensive...
Blog

Language Landscape: Latin America

As Latin America (LATAM) is becoming a key market for pharmaceutical companies, the need to connect with the patient population there has increased as well.But is translating your content from English to Spanish LATAM the right approach?As simple as this question may seem, the...
Blog

Preparing Compliant eCTD Submissions in Asia

In May 2015, the US FDA published final and binding guidance requiring submission within 24 months of certain Common Technical Documents (CTDs) in an electronic format. This was ratified in 2017 and subsequently revised in February 2020 (Rev. 7). Currently, other notifying bodies...
Blog

How to Choose and Implement a CTMS

The clinical development landscape is awash in technologies that automate everything from subject randomization (IVR/IWR) and subject study assessments and outcomes (EDC, ePRO) to trial master file (TMF) solutions.If you are like many emerging small to mid-sized biotech and...
Blog

The Summary of Safety and Clinical Performance (SSCP) for Healthcare Professionals and Patients

In 2017, the European Parliament and the Council of the European Union (EU) set a regulatory upgrade on medical devices to strengthen governance structure. This regulation update includes increased oversight of notified bodies, new requirements for transparency and traceability,...
Blog

5 Common eCOA Migration Issues

With so many clinical trials now using COAs on electronic platforms, the practice of “migration” (transferring and adapting COAs for electronic use) has become more common than ever. Without careful implementation, one minor deviation can compound across many languages, leading...